Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Citius Pharmaceuticals, Inc. (CTXR)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Sep-30-20Sep-30-19Sep-30-18Sep-30-17Sep-30-16Sep-30-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]0.10.10.10.10.10.10.00.0
            Revenue growth  0.0%0.0%0.0%20.0%50.0%-655.9%  
Cost of goods sold  0.10.10.10.10.10.10.00.0
Gross profit  0.00.00.00.00.00.00.00.0
            Gross margin  0.0%0.0%0.0%0.0%0.0%0.0%-400.3% 
Selling, general and administrative   [+]11.89.88.16.36.46.13.80.9
Research and development  17.712.28.88.66.62.92.91.8
Other operating expenses  3.91.50.80.70.81.00.80.5
EBITDA   [+]-33.3-23.5-17.7-15.6-13.8-10.0-7.4 
            EBITDA margin  -37014.6%-26144.9%-19677.6%-17330.5%-18383.2%-19967.4%82810.2% 
Depreciation and amortization  0.00.00.00.00.00.00.0 
EBIT   [+]-33.3-23.5-17.7-15.6-13.8-10.0-7.4-3.2
            EBIT margin  -37017.8%-26146.5%-19678.5%-17331.5%-18385.5%-19972.6%82825.1% 
Interest income, net   [+]0.30.30.10.0  0.00.0
Other income (expense), net   [+] 0.20.1 1.3-0.4-0.80.3
Pre-tax income  -33.1-23.1-17.5-15.6-12.5-10.4-8.3-2.9
Income taxes  0.60.00.00.00.00.00.00.0
            Tax rate   0.0% 0.0%0.0%0.0%0.0%0.0%
Net income  -33.6-24.5-17.5-15.6-12.5-10.4-8.3-2.9
            Net margin  -37378.5%-27228.1%-19497.9%-17291.3%-16715.5%-20769.9%92235.9% 
   
Basic EPS   [+]($0.23)($0.23)($0.45)($0.77)($1.17)($1.89)($2.29)($1.37)
Diluted EPS   [+]($0.23)($0.23)($0.45)($0.77)($1.17)($1.89)($2.29)($1.37)
   
Shares outstanding (basic)   [+]146.1108.639.220.210.75.53.62.1
Shares outstanding (diluted)   [+]146.1108.639.220.210.75.53.62.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy